These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32770959)

  • 1. Discussing proton pump inhibitor deprescribing: the views of Danish GPs and older patients.
    Thompson W; Nissen M; Haastrup P; Le JV; Lundby C; Nielsen JB; Jarbøl DE
    BMC Fam Pract; 2020 Aug; 21(1):160. PubMed ID: 32770959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GP preferences for discussing statin deprescribing: a discrete choice experiment.
    Thompson W; Jarbøl D; Nielsen JB; Haastrup P; Pedersen LB
    Fam Pract; 2022 Jan; 39(1):26-31. PubMed ID: 34268565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a multi-faceted intervention to deprescribe proton pump inhibitors in primary care: protocol for a population-based, pragmatic, cluster-randomized controlled trial.
    Nguyen-Soenen J; Rat C; Gaultier A; Schirr-Bonnans S; Tessier P; Fournier JP
    BMC Health Serv Res; 2022 Feb; 22(1):219. PubMed ID: 35177042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient Values and Preferences Surrounding Proton Pump Inhibitor Use: A Scoping Review.
    Thompson W; Black C; Welch V; Farrell B; Bjerre LM; Tugwell P
    Patient; 2018 Feb; 11(1):17-28. PubMed ID: 28608038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of the long-term use of proton pump inhibitors by a patient-oriented electronic decision support tool (arriba-PPI): study protocol for a randomized controlled trial.
    Rieckert A; Becker A; Donner-Banzhof N; Viniol A; Bücker B; Wilm S; Sönnichsen A; Barzel A
    Trials; 2019 Nov; 20(1):636. PubMed ID: 31752978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors which influence the deprescribing decisions of community-living older adults and GPs in Australia.
    Gillespie R; Mullan J; Harrison L
    Health Soc Care Community; 2022 Nov; 30(6):e6206-e6216. PubMed ID: 36165345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deprescribing in a family health team: a study of chronic proton pump inhibitor use.
    Walsh K; Kwan D; Marr P; Papoushek C; Lyon WK
    J Prim Health Care; 2016 Jun; 8(2):164-71. PubMed ID: 27477559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deprescribing proton pump inhibitors.
    Turner JP; Thompson W; Reeve E; Bell JS
    Aust J Gen Pract; 2022 Nov; 51(11):845-848. PubMed ID: 36310001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring how GPs discuss statin deprescribing with older people: a qualitative study.
    Thompson W; Le JV; Haastrup P; Nielsen JB; Pedersen LB; Jarbøl DE
    BJGP Open; 2020; 4(1):. PubMed ID: 32238392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful deprescribing of unnecessary proton pump inhibitors in a primary care clinic.
    Odenthal DR; Philbrick AM; Harris IM
    J Am Pharm Assoc (2003); 2020; 60(1):100-104. PubMed ID: 31601478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inappropriate proton-pump inhibitor prescribing in primary care - an observational study with quality circles.
    Vidonscky Lüthold R; Henz NC; Fuhrer C; Häner A; Schenk M; Jungo KT; Streit S
    Swiss Med Wkly; 2023 Sep; 153():40119. PubMed ID: 37769322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems Associated with Deprescribing of Proton Pump Inhibitors.
    Helgadottir H; Bjornsson ES
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and Provider Perspectives on Deprescribing Proton Pump Inhibitors.
    Ikeji C; Williams A; Hennawi G; Brandt NJ
    J Gerontol Nurs; 2019 Oct; 45(10):9-17. PubMed ID: 31560071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Implementation of a Pharmacist-Led Proton Pump Inhibitor Deprescribing Algorithm in a Geriatric Ambulatory Office.
    Leszcynski L; Bente J
    Sr Care Pharm; 2023 Mar; 38(3):105-112. PubMed ID: 36803698
    [No Abstract]   [Full Text] [Related]  

  • 17. Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners.
    Luymes CH; van der Kleij RM; Poortvliet RK; de Ruijter W; Reis R; Numans ME
    Ann Pharmacother; 2016 Jun; 50(6):446-54. PubMed ID: 26939589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of older patients' goals in GP decision-making about medicines: a qualitative study.
    Weir KR; Naganathan V; Carter SM; Tam CWM; McCaffery K; Bonner C; Rigby D; McLachlan AJ; Jansen J
    BMC Fam Pract; 2021 Jan; 22(1):13. PubMed ID: 33419389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' views on pharmacists' involvement in hospital deprescribing: A qualitative study on proton pump inhibitors.
    Gendre P; Mayol S; Mocquard J; Huon JF
    Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):718-728. PubMed ID: 37081726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study.
    Aubert CE; Blum MR; Gastens V; Dalleur O; Vaillant F; Jennings E; Aujesky D; Thompson W; Kool T; Kramers C; Knol W; O'Mahony D; Rodondi N
    CMAJ Open; 2023; 11(1):E170-E178. PubMed ID: 36854455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.